No Link Between Menopause Hormone Therapy and Dementia, Review Says

**New Research Eases Fears About Menopause Hormone Therapy and Dementia Risk** For years, women have been warned about the potential risks of menopause hormone therapy (MHT), including an increased risk of dementia.

**New Research Eases Fears About Menopause Hormone Therapy and Dementia Risk**

For years, women have been warned about the potential risks of menopause hormone therapy (MHT), including an increased risk of dementia. However, a new review of data from over 1 million women has found no link between MHT and dementia risk.

**A Shift in Perspective: Focus on Symptom Relief and Quality of Life**

According to experts, decisions about hormone therapy should focus on symptom relief and quality of life, rather than fear of cognitive decline. This shift in perspective is a welcome change for women who have been hesitant to use MHT due to concerns about dementia risk.

**The History of Menopause Hormone Therapy: A Complex and Controversial Past**

The history of MHT is complex and controversial. In the 1960s, hormone therapy was first introduced as a treatment for menopausal symptoms. However, in 2002, results from the Women's Health Initiative (WHI) suggested that the risks outweighed the benefits. Following this study, MHT therapy declined by 45%.

**New Research Challenges Previous Findings**

A new meta-analysis commissioned by the World Health Organization (WHO) has found no association between MHT and dementia risk. The study, published in The Lancet Healthy Longevity, included data from over 1 million women and provides a much-needed update on the safety of hormone therapy.

**Expert Insights: A Return to Evidence-Based Medicine**

"We are returning to evidence-based medicine and giving women control over their health again," said Health and Human Services Secretary Robert F. Kennedy Jr. This shift in perspective is a welcome change for women who have been hesitant to use MHT due to concerns about dementia risk.

**What Does this Mean for Women?**

The findings of this study suggest that decisions about hormone therapy should be guided by symptoms and well-established benefits and risks, rather than fear of cognitive decline. Clinicians and patients can now rely on evidence-based information when making decisions about MHT.

Learn more about hair transplant at Rubenhair clinic.